Abstract
Although deep brain stimulation (DBS) is an established treatment choice for Parkinson’s disease (PD), essential tremor and movement disorders, its effectiveness for the management of treatment-resistant depression (TRD) remains unclear. Herein, we conducted an integrative review on major neuroanatomical targets of DBS pursued for the treatment of intractable TRD. The aim of this review article is to provide a critical discussion of possible underlying mechanisms for DBS-generated antidepressant effects identified in preclinical studies and clinical trials, and to determine which brain target(s) elicited the most promising outcomes considering acute and maintenance treatment of TRD. Major electronic databases were searched to identify preclinical and clinical studies that have investigated the effects of DBS on depression-related outcomes. Overall, 92 references met inclusion criteria, and have evaluated six unique DBS targets namely the subcallosal cingulate gyrus (SCG), nucleus accumbens (NAc), ventral capsule/ventral striatum or anterior limb of internal capsule (ALIC), medial forebrain bundle (MFB), lateral habenula (LHb) and inferior thalamic peduncle for the treatment of unrelenting TRD. Electrical stimulation of these pertinent brain regions displayed differential effects on mood transition in patients with TRD. In addition, 47 unique references provided preclinical evidence for putative neurobiological mechanisms underlying antidepressant effects of DBS applied to the ventromedial prefrontal cortex, NAc, MFB, LHb and subthalamic nucleus. Preclinical studies suggest that stimulation parameters and neuroanatomical locations could influence DBS-related antidepressant effects, and also pointed that modulatory effects on monoamine neurotransmitters in target regions or interconnected brain networks following DBS could have a role in the antidepressant effects of DBS. Among several neuromodulatory targets that have been investigated, DBS in the neuroanatomical framework of the SCG, ALIC and MFB yielded more consistent antidepressant response rates in samples with TRD. Nevertheless, more well-designed randomized double-blind, controlled trials are warranted to further assess the efficacy, safety and tolerability of these more promising DBS targets for the management of TRD as therapeutic effects have been inconsistent across some controlled studies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, de Girolamo G et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med 2011; 9: 90.
Kessler RC, Bromet EJ . The epidemiology of depression across cultures. Annu Rev Public Health 2013; 34: 119–138.
Anderson RJ, Frye MA, Abulseoud OA, Lee KH, McGillivray JA, Berk M et al. Deep brain stimulation for treatment-resistant depression: efficacy, safety and mechanisms of action. Neurosci Biobehav Rev 2012; 36: 1920–1933.
Rosenblat JD, McIntyre RS, Alves GS, Fountoulakis KN, Carvalho AF . Beyond monoamines-novel targets for treatment-resistant depression: a comprehensive review. Curr Neuropharmacol 2015; 13: 636–655.
Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 2006; 354: 1231–1242.
Carvalho AF, Berk M, Hyphantis TN, McIntyre RS . The integrative management of treatment-resistant depression: a comprehensive review and perspectives. Psychother Psychosom 2014; 83: 70–88.
Souery D, Papakostas GI, Trivedi MH . Treatment-resistant depression. J Clin Psychiatry 2006; 67 (Suppl 6): 16–22.
McIntyre RS, Filteau MJ, Martin L, Patry S, Carvalho A, Cha DS et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord 2014; 156: 1–7.
Berlim MT, Turecki G . What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials. Eur Neuropsychopharmacol 2007; 17: 696–707.
Carvalho AF, Sharma MS, Brunoni AR, Vieta E, Fava GA . The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature. Psychother Psychosom 2016; 85: 270–288.
Mrazek DA, Hornberger JC, Altar CA, Degtiar I . A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013. Psychiatr Serv 2014; 65: 977–987.
Papakostas GI, Ionescu DF . Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder. Mol Psychiatry 2015; 20: 1142–1150.
Zarate CA Jr., Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63: 856–864.
Papadimitropoulou K, Vossen C, Karabis A, Donatti C, Kubitz N . Comparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: a systematic review and network meta-analysis. Curr Med Res Opin 2017; 33: 701–711.
Sanacora G, Frye MA, McDonald W, Mathew SJ, Turner MS, Schatzberg AF et al. A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry 2017; 74: 399–405.
Dumitriu D, Collins K, Alterman R, Mathew SJ . Neurostimulatory therapeutics in management of treatment-resistant depression with focus on deep brain stimulation. Mount Sinai J Med 2008; 75: 263–275.
Mohr P, Rodriguez M, Slavickova A, Hanka J . The application of vagus nerve stimulation and deep brain stimulation in depression. Neuropsychobiology 2011; 64: 170–181.
Rizvi SJ, Donovan M, Giacobbe P, Placenza F, Rotzinger S, Kennedy SH . Neurostimulation therapies for treatment resistant depression: a focus on vagus nerve stimulation and deep brain stimulation. Int Rev Psychiatry 2011; 23: 424–436.
Blumberger DM, Mulsant BH, Daskalakis ZJ . What is the role of brain stimulation therapies in the treatment of depression? Curr Psychiatr Rep 2013; 15: 368.
Kopell BH, Halverson J, Butson CR, Dickinson M, Bobholz J, Harsch H et al. Epidural cortical stimulation of the left dorsolateral prefrontal cortex for refractory major depressive disorder. Neurosurgery 2011; 69: 1015–1029, discussion 1029.
Tye SJ, Frye MA, Lee KH . Disrupting disordered neurocircuitry: treating refractory psychiatric illness with neuromodulation. Mayo Clin Proc 2009; 84: 522–532.
Benabid AL, Benazzouz A, Hoffmann D, Limousin P, Krack P, Pollak P . Long-term electrical inhibition of deep brain targets in movement disorders. Mov Disord 1998; 13 (Suppl 3): 119–125.
Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J . Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Applied Neurophysiol 1987; 50: 344–346.
Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005; 45: 651–660.
Kuhn J, Huff W . Will deep brain stimulation be as successful in major depression as it has been in Parkinson's disease? Exp Rev Neurother 2010; 10: 1363–1365.
Alonso P, Cuadras D, Gabriels L, Denys D, Goodman W, Greenberg BD et al. Deep brain stimulation for obsessive-compulsive disorder: a meta-analysis of treatment outcome and predictors of response. PLoS ONE 2015; 10: e0133591.
Lally N, Nugent AC, Luckenbaugh DA, Ameli R, Roiser JP, Zarate CA . Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression. Transl Psychiatry 2014; 4: e469.
Carlson PJ, Diazgranados N, Nugent AC, Ibrahim L, Luckenbaugh DA, Brutsche N et al. Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study. Biol Psychiatry 2013; 73: 1213–1221.
McIntyre CC, Savasta M, Kerkerian-Le Goff L, Vitek JL . Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both. Clin Neurophysiol 2004; 115: 1239–1248.
Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999; 156: 675–682.
Johansen-Berg H, Gutman DA, Behrens TE, Matthews PM, Rushworth MF, Katz E et al. Anatomical connectivity of the subgenual cingulate region targeted with deep brain stimulation for treatment-resistant depression. Cereb Cortex 2008; 18: 1374–1383.
Malone DA Jr., Dougherty DD, Rezai AR, Carpenter LL, Friehs GM, Eskandar EN et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry 2009; 65: 267–275.
Schlaepfer TE, Bewernick BH, Kayser S, Madler B, Coenen VA . Rapid effects of deep brain stimulation for treatment-resistant major depression. Biol Psychiatry 2013; 73: 1204–1212.
Schlaepfer TE, Cohen MX, Frick C, Kosel M, Brodesser D, Axmacher N et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 2008; 33: 368–377.
Bewernick BH, Kayser S, Gippert SM, Switala C, Coenen VA, Schlaepfer TE . Deep brain stimulation to the medial forebrain bundle for depression- long-term outcomes and a novel data analysis strategy. Brain Stimul 2017; 10: 664–671.
Bewernick BH, Kayser S, Sturm V, Schlaepfer TE . Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy. Neuropsychopharmacology 2012; 37: 1975–1985.
Taghva AS, Malone DA, Rezai AR . Deep brain stimulation for treatment-resistant depression. World Neurosurg 2013; 80: S27 e17-24.
Morishita T, Fayad SM, Higuchi MA, Nestor KA, Foote KD . Deep brain stimulation for treatment-resistant depression: systematic review of clinical outcomes. Neurotherapeutics 2014; 11: 475–484.
Fenoy AJ, Schulz P, Selvaraj S, Burrows C, Spiker D, Cao B et al. Deep brain stimulation of the medial forebrain bundle: distinctive responses in resistant depression. J Affect Disord 2016; 203: 143–151.
Mayberg HS, Riva-Posse P, Crowell AL . Deep brain stimulation for depression: keeping an eye on a moving target. JAMA Psychiatry 2016; 73: 439–440.
Smith DF . Exploratory meta-analysis on deep brain stimulation in treatment-resistant depression. Acta Neuropsychiatr 2014; 26: 382–384.
Hamani C, Nobrega JN . Deep brain stimulation in clinical trials and animal models of depression. Eur J Neurosci 2010; 32: 1109–1117.
Nestler EJ, Hyman SE . Animal models of neuropsychiatric disorders. Nat Neurosci 2010; 13: 1161–1169.
Drevets WC, Savitz J, Trimble M . The subgenual anterior cingulate cortex in mood disorders. CNS Spectr 2008; 13: 663–681.
Riva-Posse P, Choi KS, Holtzheimer PE, Crowell AL, Garlow SJ, Rajendra JK et al. A connectomic approach for subcallosal cingulate deep brain stimulation surgery: prospective targeting in treatment-resistant depression. Mol Psychiatry 2017 article in press.
Riva-Posse P, Holtzheimer PE, Garlow SJ, Mayberg HS . Practical considerations in the development and refinement of subcallosal cingulate white matter deep brain stimulation for treatment-resistant depression. World Neurosurg 2013; 80: S27 e25–S27 e34.
Lozano AM, Mayberg HS, Giacobbe P, Hamani C, Craddock RC, Kennedy SH . Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry 2008; 64: 461–467.
Puigdemont D, Portella MJ, Perez-Egea R, de Diego-Adelino J, Gironell A, Molet J et al. Depressive relapse after initial response to subcallosal cingulate gyrus-deep brain stimulation in a patient with a treatment-resistant depression: electroconvulsive therapy as a feasible strategy. Biol Psychiatry 2009; 66: e11–e12.
Neimat JS, Hamani C, Giacobbe P, Merskey H, Kennedy SH, Mayberg HS et al. Neural stimulation successfully treats depression in patients with prior ablative cingulotomy. Am J Psychiatry 2008; 165: 687–693.
Torres CV, Ezquiaga E, Navas M, de Sola RG . Deep brain stimulation of the subcallosal cingulate for medication-resistant type I bipolar depression: case report. Bipolar Disord 2013; 15: 719–721.
Funayama M, Kato M, Mimura M . Disappearance of treatment-resistant depression after damage to the orbitofrontal cortex and subgenual cingulate area: a case study. BMC Neurol 2016; 16: 198.
Holtzheimer PE 3rd, Mayberg HS . Deep brain stimulation for treatment-resistant depression. Am J Psychiatry 2010; 167: 1437–1444.
Kennedy SH, Giacobbe P, Rizvi SJ, Placenza FM, Nishikawa Y, Mayberg HS et al. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am J Psychiatry 2011; 168: 502–510.
Holtzheimer PE, Kelley ME, Gross RE, Filkowski MM, Garlow SJ, Barrocas A et al. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry 2012; 69: 150–158.
Puigdemont D, Perez-Egea R, Portella MJ, Molet J, de Diego-Adelino J, Gironell A et al. Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression. Int J Neuropsychopharmacol 2012; 15: 121–133.
Martin-Blanco A, Serra-Blasco M, Perez-Egea R, de Diego-Adelino J, Carceller-Sindreu M, Puigdemont D et al. Immediate cerebral metabolic changes induced by discontinuation of deep brain stimulation of subcallosal cingulate gyrus in treatment-resistant depression. J Affect Disord 2015; 173: 159–162.
Puigdemont D, Portella M, Perez-Egea R, Molet J, Gironell A, de Diego-Adelino J et al. A randomized double-blind crossover trial of deep brain stimulation of the subcallosal cingulate gyrus in patients with treatment-resistant depression: a pilot study of relapse prevention. J Psychiatr Neurosci 2015; 40: 224–231.
Eitan R, Fontaine D, Benoit M, Giordana C, Darmon N, Israel Z et al. One year double blind study of high vs low frequency subcallosal cingulate stimulation for depression. J Psychiatr Res 2018; 96: 124–134.
Berlim MT, McGirr A, Van den Eynde F, Fleck MP, Giacobbe P . Effectiveness and acceptability of deep brain stimulation (DBS) of the subgenual cingulate cortex for treatment-resistant depression: a systematic review and exploratory meta-analysis. J Affect Disord 2014; 159: 31–38.
Merkl A, Schneider GH, Schonecker T, Aust S, Kuhl KP, Kupsch A et al. Antidepressant effects after short-term and chronic stimulation of the subgenual cingulate gyrus in treatment-resistant depression. Exp Neurol 2013; 249: 160–168.
Ramasubbu R, Anderson S, Haffenden A, Chavda S, Kiss ZH . Double-blind optimization of subcallosal cingulate deep brain stimulation for treatment-resistant depression: a pilot study. J Psychiatr Neurosci 2013; 38: 325–332.
Lozano AM, Giacobbe P, Hamani C, Rizvi SJ, Kennedy SH, Kolivakis TT et al. A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. J Neurosurg 2012; 116: 315–322.
Lujan JL, Chaturvedi A, Choi KS, Holtzheimer PE, Gross RE, Mayberg HS et al. Tractography-activation models applied to subcallosal cingulate deep brain stimulation. Brain Stimul 2013; 6: 737–739.
Riva-Posse P, Choi KS, Holtzheimer PE, McIntyre CC, Gross RE, Chaturvedi A et al. Defining critical white matter pathways mediating successful subcallosal cingulate deep brain stimulation for treatment-resistant depression. Biol Psychiatry 2014; 76: 963–969.
Holtzheimer PE, Mayberg HS . Deep brain stimulation for psychiatric disorders. Annu Rev Neurosci 2011; 34: 289–307.
Moreines JL, McClintock SM, Kelley ME, Holtzheimer PE, Mayberg HS . Neuropsychological function before and after subcallosal cingulate deep brain stimulation in patients with treatment-resistant depression. Depress Anxiety 2014; 31: 690–698.
Bogod NM, Sinden M, Woo C, Defreitas VG, Torres IJ, Howard AK et al. Long-term neuropsychological safety of subgenual cingulate gyrus deep brain stimulation for treatment-resistant depression. J Neuropsychiatr Clin Neurosci 2014; 26: 126–133.
Hilimire MR, Mayberg HS, Holtzheimer PE, Broadway JM, Parks NA, DeVylder JE et al. Effects of subcallosal cingulate deep brain stimulation on negative self-bias in patients with treatment-resistant depression. Brain Stimul 2015; 8: 185–191.
Serra-Blasco M, de Vita S, Rodriguez MR, de Diego-Adelino J, Puigdemont D, Martin-Blanco A et al. Cognitive functioning after deep brain stimulation in subcallosal cingulate gyrus for treatment-resistant depression: an exploratory study. Psychiatr Res 2015; 225: 341–346.
McInerney SJ, McNeely HE, Geraci J, Giacobbe P, Rizvi SJ, Ceniti AK et al. Neurocognitive predictors of response in treatment resistant depression to subcallosal cingulate gyrus deep brain stimulation. Front Hum Neurosci 2017; 11: 74.
McNeely HE, Mayberg HS, Lozano AM, Kennedy SH . Neuropsychological impact of Cg25 deep brain stimulation for treatment-resistant depression: preliminary results over 12 months. JNerv Ment Dis 2008; 196: 405–410.
Crowell AL, Garlow SJ, Riva-Posse P, Mayberg HS . Characterizing the therapeutic response to deep brain stimulation for treatment-resistant depression: a single center long-term perspective. Front Integr Neurosci 2015; 9: 41.
Saleh C, Fontaine D . Deep brain stimulation for psychiatric diseases: what are the risks? Curr Psychiatr Rep 2015; 17: 33.
Richieri R, Borius PY, Lagrange G, Faget-Agius C, Guedj E, Mc Gonigal A et al. Unmasking partial seizure after deep brain stimulation for treatment-resistant depression: a case report. Brain Stimul 2016; 9: 636–638.
Holtzheimer PE, Husain MM, Lisanby SH, Taylor SF, Whitworth LA, McClintock S et al. Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial. Lancet Psychiatry 2017; 4: 839–849.
Merkl A, Aust S, Schneider GH, Visser-Vandewalle V, Horn A, Kuhn AA et al. Deep brain stimulation of the subcallosal cingulate gyrus in patients with treatment-resistant depression: a double-blinded randomized controlled study and long-term follow-up in eight patients. J Affect Disord 2017; 227: 521–529.
Accolla EA, Aust S, Merkl A, Schneider GH, Kuhn AA, Bajbouj M et al. Deep brain stimulation of the posterior gyrus rectus region for treatment resistant depression. J Affect Disord 2016; 194: 33–37.
Wallis JD . Cross-species studies of orbitofrontal cortex and value-based decision-making. Nat Neurosci 2011; 15: 13–19.
Hamani C, Diwan M, Isabella S, Lozano AM, Nobrega JN . Effects of different stimulation parameters on the antidepressant-like response of medial prefrontal cortex deep brain stimulation in rats. J Psychiatr Res 2010a; 44: 683–687.
Hamani C, Diwan M, Macedo CE, Brandao ML, Shumake J, Gonzalez-Lima F et al. Antidepressant-like effects of medial prefrontal cortex deep brain stimulation in rats. Biol Psychiatry 2010b; 67: 117–124.
Hamani C, Giacobbe P, Diwan M, Balbino ES, Tong J, Bridgman A et al. Monoamine oxidase inhibitors potentiate the effects of deep brain stimulation. Am J Psychiatry 2012a; 169: 1320–1321.
Hamani C, Machado DC, Hipolide DC, Dubiela FP, Suchecki D, Macedo CE et al. Deep brain stimulation reverses anhedonic-like behavior in a chronic model of depression: role of serotonin and brain derived neurotrophic factor. Biol Psychiatry 2012b; 71: 30–35.
Li B, Piriz J, Mirrione M, Chung C, Proulx CD, Schulz D et al. Synaptic potentiation onto habenula neurons in the learned helplessness model of depression. Nature 2011; 470: 535–539.
Meng H, Wang Y, Huang M, Lin W, Wang S, Zhang B . Chronic deep brain stimulation of the lateral habenula nucleus in a rat model of depression. Brain Res 2011; 1422: 32–38.
Perez-Caballero L, Perez-Egea R, Romero-Grimaldi C, Puigdemont D, Molet J, Caso JR et al. Early responses to deep brain stimulation in depression are modulated by anti-inflammatory drugs. Mol Psychiatry 2014; 19: 607–614.
Lim LW, Janssen ML, Kocabicak E, Temel Y . The antidepressant effects of ventromedial prefrontal cortex stimulation is associated with neural activation in the medial part of the subthalamic nucleus. Behav Brain Res 2015a; 279: 17–21.
Lim LW, Prickaerts J, Huguet G, Kadar E, Hartung H, Sharp T et al. Electrical stimulation alleviates depressive-like behaviors of rats: investigation of brain targets and potential mechanisms. Transl Psychiatry 2015b; 5: e535.
Jimenez-Sanchez L, Castane A, Perez-Caballero L, Grifoll-Escoda M, Lopez-Gil X, Campa L et al. Activation of AMPA receptors mediates the antidepressant action of deep brain stimulation of the infralimbic prefrontal cortex. Cereb cortex 2016a; 26: 2778–2789.
Jimenez-Sanchez L, Linge R, Campa L, Valdizan EM, Pazos A, Diaz A et al. Behavioral, neurochemical and molecular changes after acute deep brain stimulation of the infralimbic prefrontal cortex. Neuropharmacology 2016b; 108: 91–102.
Rea E, Rummel J, Schmidt TT, Hadar R, Heinz A, Mathe AA et al. Anti-anhedonic effect of deep brain stimulation of the prefrontal cortex and the dopaminergic reward system in a genetic rat model of depression: an intracranial self-stimulation paradigm study. Brain Stimul 2014; 7: 21–28.
Schmuckermair C, Gaburro S, Sah A, Landgraf R, Sartori SB, Singewald N . Behavioral and neurobiological effects of deep brain stimulation in a mouse model of high anxiety- and depression-like behavior. Neuropsychopharmacology 2013; 38: 1234–1244.
Edemann-Callesen H, Voget M, Empl L, Vogel M, Wieske F, Rummel J et al. Medial forebrain bundle deep brain stimulation has symptom-specific anti-depressant effects in rats and as opposed to ventromedial prefrontal cortex stimulation interacts with the reward system. Brain Stimul 2015; 8: 714–723.
Gersner R, Toth E, Isserles M, Zangen A . Site-specific antidepressant effects of repeated subconvulsive electrical stimulation: potential role of brain-derived neurotrophic factor. Biol Psychiatry 2010; 67: 125–132.
Veerakumar A, Challis C, Gupta P, Da J, Upadhyay A, Beck SG et al. Antidepressant-like effects of cortical deep brain stimulation coincide with pro-neuroplastic adaptations of serotonin systems. Biol Psychiatry 2014; 76: 203–212.
Moshe H, Gal R, Barnea-Ygael N, Gulevsky T, Alyagon U, Zangen A . Prelimbic stimulation ameliorates depressive-like behaviors and increases regional bdnf expression in a novel drug-resistant animal model of depression. Brain Stimul 2016; 9: 243–250.
Etievant A, Oosterhof C, Betry C, Abrial E, Novo-Perez M, Rovera R et al. Astroglial control of the antidepressant-like effects of prefrontal cortex deep brain stimulation. EBioMedicine 2015a; 2: 898–908.
Insel N, Pilkiw M, Nobrega JN, Hutchison WD, Takehara-Nishiuchi K, Hamani C . Chronic deep brain stimulation of the rat ventral medial prefrontal cortex disrupts hippocampal-prefrontal coherence. Exp Neurol 2015; 269: 1–7.
Bezchlibnyk YB, Stone SS, Hamani C, Lozano AM . High frequency stimulation of the infralimbic cortex induces morphological changes in rat hippocampal neurons. Brain Stimul 2017; 10: 315–323.
Parthoens J, Verhaeghe J, Stroobants S, Staelens S . Deep brain stimulation of the prelimbic medial prefrontal cortex: quantification of the effect on glucose metabolism in the rat brain using [(18) F]FDG microPET. Mol Imaging Biol 2014; 16: 838–845.
Dournes C, Beeske S, Belzung C, Griebel G . Deep brain stimulation in treatment-resistant depression in mice: comparison with the CRF1 antagonist, SSR125543. Progr Neuropsychopharmacol Biol Psychiatry 2013; 40: 213–220.
Bambico FR, Bregman T, Diwan M, Li J, Darvish-Ghane S, Li Z et al. Neuroplasticity-dependent and -independent mechanisms of chronic deep brain stimulation in stressed rats. Transl Psychiatry 2015; 5: e674.
Chakravarty MM, Hamani C, Martinez-Canabal A, Ellegood J, Laliberte C, Nobrega JN et al. Deep brain stimulation of the ventromedial prefrontal cortex causes reorganization of neuronal processes and vasculature. NeuroImage 2016; 125: 422–427.
Bregman T, Nona C, Volle J, Diwan M, Raymond R, Fletcher PJ et al. Deep brain stimulation induces antidepressant-like effects in serotonin transporter knockout mice. Brain Stimul 2018; 11: 423–425.
Srejic LR, Hamani C, Hutchison WD . High-frequency stimulation of the medial prefrontal cortex decreases cellular firing in the dorsal raphe. Eur J Neurosci 2015; 41: 1219–1226.
Laver B, Diwan M, Nobrega JN, Hamani C . Augmentative therapies do not potentiate the antidepressant-like effects of deep brain stimulation in rats. J Affect Disord 2014; 161: 87–90.
Bruchim-Samuel M, Lax E, Gazit T, Friedman A, Ahdoot H, Bairachnaya M et al. Electrical stimulation of the vmPFC serves as a remote control to affect VTA activity and improve depressive-like behavior. Exp Neurol 2016; 283 (Pt A): 255–263.
Torres-Sanchez S, Perez-Caballero L, Mico JA, Celada P, Berrocoso E . Effect of Deep Brain Stimulation of the ventromedial prefrontal cortex on the noradrenergic system in rats. Brain Stimul 2017; 11: 222–230.
Mayberg HS . Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatr Clin Neurosci 1997; 9: 471–481.
Hamani C, Mayberg H, Stone S, Laxton A, Haber S, Lozano AM . The subcallosal cingulate gyrus in the context of major depression. Biol Psychiatry 2011; 69: 301–308.
Etievant A, Lucas G, Dkhissi-Benyahya O, Haddjeri N . The role of astroglia in the antidepressant action of deep brain stimulation. Front Cell Neurosci 2015b; 9: 509.
Hamani C, Nobrega JN . Reply to: deep brain stimulation for depression: is it a gray or white "matter"? Biol Psychiatry 2016; 80: e45.
Laxton AW, Lipsman N, Lozano AM . Deep brain stimulation for cognitive disorders. Handb Clin Neurol 2013; 116: 307–311.
Eggers AE . Treatment of depression with deep brain stimulation works by altering in specific ways the conscious perception of the core symptoms of sadness or anhedonia, not by modulating network circuitry. Med Hypotheses 2014; 83: 62–64.
Broadway JM, Holtzheimer PE, Hilimire MR, Parks NA, Devylder JE, Mayberg HS et al. Frontal theta cordance predicts 6-month antidepressant response to subcallosal cingulate deep brain stimulation for treatment-resistant depression: a pilot study. Neuropsychopharmacology 2012; 37: 1764–1772.
Neumann WJ, Huebl J, Brucke C, Gabriels L, Bajbouj M, Merkl A et al. Different patterns of local field potentials from limbic DBS targets in patients with major depressive and obsessive compulsive disorder. Mol Psychiatry 2014; 19: 1186–1192.
Quraan MA, Protzner AB, Daskalakis ZJ, Giacobbe P, Tang CW, Kennedy SH et al. EEG power asymmetry and functional connectivity as a marker of treatment effectiveness in DBS surgery for depression. Neuropsychopharmacology 2014; 39: 1270–1281.
Sun Y, Giacobbe P, Tang CW, Barr MS, Rajji T, Kennedy SH et al. Deep brain stimulation modulates gamma oscillations and theta-gamma coupling in treatment resistant depression. Brain Stimul 2015; 8: 1033–1042.
Bewernick BH, Hurlemann R, Matusch A, Kayser S, Grubert C, Hadrysiewicz B et al. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry 2010; 67: 110–116.
Grubert C, Hurlemann R, Bewernick BH, Kayser S, Hadrysiewicz B, Axmacher N et al. Neuropsychological safety of nucleus accumbens deep brain stimulation for major depression: effects of 12-month stimulation. World J Biol Psychiatry 2011; 12: 516–527.
Millet B, Jaafari N, Polosan M, Baup N, Giordana B, Haegelen C et al. Limbic versus cognitive target for deep brain stimulation in treatment-resistant depression: accumbens more promising than caudate. Eur Neuropsychopharmacol 2014; 24: 1229–1239.
Sesia T, Bulthuis V, Tan S, Lim LW, Vlamings R, Blokland A et al. Deep brain stimulation of the nucleus accumbens shell increases impulsive behavior and tissue levels of dopamine and serotonin. Exp Neurol 2010; 225: 302–309.
van Dijk A, Mason O, Klompmakers AA, Feenstra MG, Denys D . Unilateral deep brain stimulation in the nucleus accumbens core does not affect local monoamine release. J Neurosci Methods 2011; 202: 113–118.
van Dijk A, Klompmakers AA, Feenstra MG, Denys D . Deep brain stimulation of the accumbens increases dopamine, serotonin, and noradrenaline in the prefrontal cortex. J Neurochem 2012; 123: 897–903.
McCracken CB, Grace AA . Nucleus accumbens deep brain stimulation produces region-specific alterations in local field potential oscillations and evoked responses in vivo. J Neurosci 2009; 29: 5354–5363.
van der Plasse G, Schrama R, van Seters SP, Vanderschuren LJ, Westenberg HG . Deep brain stimulation reveals a dissociation of consummatory and motivated behaviour in the medial and lateral nucleus accumbens shell of the rat. PLoS ONE 2012; 7: e33455.
Hamani C, Amorim BO, Wheeler AL, Diwan M, Driesslein K, Covolan L et al. Deep brain stimulation in rats: different targets induce similar antidepressant-like effects but influence different circuits. Neurobiol Dis 2014; 71: 205–214.
Rummel J, Voget M, Hadar R, Ewing S, Sohr R, Klein J et al. Testing different paradigms to optimize antidepressant deep brain stimulation in different rat models of depression. J Psychiatr Res 2016; 81: 36–45.
Kim Y, McGee S, Czeczor JK, Walker AJ, Kale RP, Kouzani AZ et al. Nucleus accumbens deep brain stimulation efficacy in ACTH-pretreated rats: alterations in mitochondrial function relate to antidepressant-like effects. Transl Psychiatry 2016a; 6: e842.
Falowski SM, Sharan A, Reyes BA, Sikkema C, Szot P, Van Bockstaele EJ . An evaluation of neuroplasticity and behavior after deep brain stimulation of the nucleus accumbens in an animal model of depression. Neurosurgery 2011; 69: 1281–1290.
Winter C, Bregman T, Voget M, Raymond R, Hadar R, Nobrega JN et al. Acute high frequency stimulation of the prefrontal cortex or nucleus accumbens does not increase hippocampal neurogenesis in rats. J Psychiatr Res 2015; 68: 27–29.
Huguet G, Kadar E, Temel Y, Lim LW . Electrical stimulation normalizes c-Fos expression in the deep cerebellar nuclei of depressive-like rats: implication of antidepressant activity. Cerebellum 2017; 16: 398–410.
Knight EJ, Min HK, Hwang SC, Marsh MP, Paek S, Kim I et al. Nucleus accumbens deep brain stimulation results in insula and prefrontal activation: a large animal FMRI study. PLoS ONE 2013; 8: e56640.
Aouizerate B, Cuny E, Martin-Guehl C, Guehl D, Amieva H, Benazzouz A et al. Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report. J Neurosurg 2004; 101: 682–686.
van den Munckhof P, Bosch DA, Mantione MH, Figee M, Denys DA, Schuurman PR . Active stimulation site of nucleus accumbens deep brain stimulation in obsessive-compulsive disorder is localized in the ventral internal capsule. Acta Neurochir Suppl 2013; 117: 53–59.
Malone DA Jr. . Use of deep brain stimulation in treatment-resistant depression. Cleveland Clin J Med 2010; 77 (Suppl 3): S77–S80.
Strong DR, Haber SN, Tyrka AR, Bernier JA, Rassmussen SA, Greenberg BD . Reversible increase in smoking after withdrawal of ventral capsule/ventral striatum deep brain stimulation in a depressed smoker. J Addict Med 2012; 6: 94–95.
Dougherty DD, Rezai AR, Carpenter LL, Howland RH, Bhati MT, O'Reardon JP et al. A randomized sham-controlled trial of deep brain stimulation of the ventral capsule/ventral striatum for chronic treatment-resistant depression. Biol Psychiatry 2015; 78: 240–248.
Richardson RM, Ghuman AS, Karp JF . Results of the first randomized controlled trial of deep brain stimulation in treatment-resistant depression. Neurosurgery 2015; 77: N23–N24.
Kubu CS, Brelje T, Butters MA, Deckersbach T, Malloy P, Moberg P et al. Cognitive outcome after ventral capsule/ventral striatum stimulation for treatment-resistant major depression. J Neurol Neurosurg Psychiatry 2017; 88: 262–265.
Bergfeld IO, Mantione M, Hoogendoorn ML, Ruhe HG, Notten P, van Laarhoven J et al. Deep brain stimulation of the ventral anterior limb of the internal capsule for treatment-resistant depression: a randomized clinical trial. JAMA Psychiatry 2016; 73: 456–464.
Bergfeld IO, Mantione M, Hoogendoorn MLC, Ruhe HG, Horst F, Notten P et al. Impact of deep brain stimulation of the ventral anterior limb of the internal capsule on cognition in depression. Psychol Med 2017; 47: 1647–1658.
Rauch SL, Dougherty DD, Malone D, Rezai A, Friehs G, Fischman AJ et al. A functional neuroimaging investigation of deep brain stimulation in patients with obsessive-compulsive disorder. J Neurosurg 2006; 104: 558–565.
Van Laere K, Nuttin B, Gabriels L, Dupont P, Rasmussen S, Greenberg BD et al. Metabolic imaging of anterior capsular stimulation in refractory obsessive-compulsive disorder: a key role for the subgenual anterior cingulate and ventral striatum. J Nucl Med 2006; 47: 740–747.
Forray MI, Gysling K . Role of noradrenergic projections to the bed nucleus of the stria terminalis in the regulation of the hypothalamic-pituitary-adrenal axis. Brain Res Brain Res Rev 2004; 47: 145–160.
Epstein J, Pan H, Kocsis JH, Yang Y, Butler T, Chusid J et al. Lack of ventral striatal response to positive stimuli in depressed versus normal subjects. Am J Psychiatry 2006; 163: 1784–1790.
Blomstedt P, Naesstrom M, Bodlund O . Deep brain stimulation in the bed nucleus of the stria terminalis and medial forebrain bundle in a patient with major depressive disorder and anorexia nervosa. Clin Case Rep 2017; 5: 679–684.
Mavridis IN . Deep brain stimulation for psychiatric disorders: Are nucleus accumbens and medial forebrain bundle two branches of the same tree? Neurosci Biobehav Rev 2015; 56: 345–346.
Furlanetti LL, Coenen VA, Aranda IA, Dobrossy MD . Chronic deep brain stimulation of the medial forebrain bundle reverses depressive-like behavior in a hemiparkinsonian rodent model. Exp Brain Res 2015a; 233: 3073–3085.
Furlanetti LL, Dobrossy MD, Aranda IA, Coenen VA . Feasibility and safety of continuous and chronic bilateral deep brain stimulation of the medial forebrain bundle in the naive Sprague-Dawley rat. Behav Neurol 2015b; 2015: 256196.
Bregman T, Reznikov R, Diwan M, Raymond R, Butson CR, Nobrega JN et al. Antidepressant-like effects of medial forebrain bundle deep brain stimulation in rats are not associated with accumbens dopamine release. Brain Stimul 2015; 8: 708–713.
Furlanetti LL, Coenen VA, Dobrossy MD . Ventral tegmental area dopaminergic lesion-induced depressive phenotype in the rat is reversed by deep brain stimulation of the medial forebrain bundle. Behav Brain Res 2016; 299: 132–140.
Dandekar MP, Luse D, Hoffmann C, Cotton P, Peery T, Ruiz C et al. Increased dopamine receptor expression and anti-depressant response following deep brain stimulation of the medial forebrain bundle. J Affect Disord 2017; 217: 80–88.
Coenen VA, Honey CR, Hurwitz T, Rahman AA, McMaster J, Burgel U et al. Medial forebrain bundle stimulation as a pathophysiological mechanism for hypomania in subthalamic nucleus deep brain stimulation for Parkinson's disease. Neurosurgery 2009; 64: 1106–1114, discussion 1114-1105.
Cho YT, Fromm S, Guyer AE, Detloff A, Pine DS, Fudge JL et al. Nucleus accumbens, thalamus and insula connectivity during incentive anticipation in typical adults and adolescents. NeuroImage 2013; 66: 508–521.
Galvez JF, Keser Z, Mwangi B, Ghouse AA, Fenoy AJ, Schulz PE et al. The medial forebrain bundle as a deep brain stimulation target for treatment resistant depression: a review of published data. Progr Neuropsychopharmacol Biol Psychiatry 2015; 58: 59–70.
Coenen VA, Panksepp J, Hurwitz TA, Urbach H, Madler B . Human medial forebrain bundle (MFB) and anterior thalamic radiation (ATR): imaging of two major subcortical pathways and the dynamic balance of opposite affects in understanding depression. J Neuropsychiatr Clin Neurosci 2012a; 24: 223–236.
Coenen VA, Schlaepfer TE, Maedler B, Panksepp J . Cross-species affective functions of the medial forebrain bundle-implications for the treatment of affective pain and depression in humans. Neurosci Biobehav Rev 2011; 35: 1971–1981.
Sesack SR, Pickel VM . Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neurol 1992; 320: 145–160.
You ZB, Chen YQ, Wise RA . Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation. Neuroscience 2001; 107: 629–639.
Ferenczi EA, Zalocusky KA, Liston C, Grosenick L, Warden MR, Amatya D et al. Prefrontal cortical regulation of brainwide circuit dynamics and reward-related behavior. Science 2016; 351: aac9698.
Taber MT, Das S, Fibiger HC . Cortical regulation of subcortical dopamine release: mediation via the ventral tegmental area. J Neurochem 1995; 65: 1407–1410.
Sartorius A, Henn FA . Deep brain stimulation of the lateral habenula in treatment resistant major depression. Med Hypotheses 2007; 69: 1305–1308.
Sartorius A, Kiening KL, Kirsch P, von Gall CC, Haberkorn U, Unterberg AW et al. Remission of major depression under deep brain stimulation of the lateral habenula in a therapy-refractory patient. Biol Psychiatry 2010; 67: e9–e11.
Friedman A, Lax E, Dikshtein Y, Abraham L, Flaumenhaft Y, Sudai E et al. Electrical stimulation of the lateral habenula produces an inhibitory effect on sucrose self-administration. Neuropharmacology 2011; 60: 381–387.
Kim Y, Morath B, Hu C, Byrne LK, Sutor SL, Frye MA et al. Antidepressant actions of lateral habenula deep brain stimulation differentially correlate with CaMKII/GSK3/AMPK signaling locally and in the infralimbic cortex. Behav Brain Res 2016b; 306: 170–177.
Christoph GR, Leonzio RJ, Wilcox KS . Stimulation of the lateral habenula inhibits dopamine-containing neurons in the substantia nigra and ventral tegmental area of the rat. J Neurosci 1986; 6: 613–619.
Ji H, Shepard PD . Lateral habenula stimulation inhibits rat midbrain dopamine neurons through a GABA(A) receptor-mediated mechanism. J Neurosci 2007; 27: 6923–6930.
Kiening K, Sartorius A . A new translational target for deep brain stimulation to treat depression. EMBO Mol Med 2013; 5: 1151–1153.
Geisler S, Trimble M . The lateral habenula: no longer neglected. CNS Spectr 2008; 13: 484–489.
Kopell BH, Greenberg BD . Anatomy and physiology of the basal ganglia: implications for DBS in psychiatry. Neurosci Biobehav Rev 2008; 32: 408–422.
Drevets WC . Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Progr Brain Res 2000; 126: 413–431.
Velasco M, Velasco F, Jimenez F, Carrillo-Ruiz JD, Velasco AL, Salin-Pascual R . Electrocortical and behavioral responses elicited by acute electrical stimulation of inferior thalamic peduncle and nucleus reticularis thalami in a patient with major depression disorder. Clin Neurophysiol 2006; 117: 320–327.
Jimenez F, Velasco F, Salin-Pascual R, Hernandez JA, Velasco M, Criales JL et al. A patient with a resistant major depression disorder treated with deep brain stimulation in the inferior thalamic peduncle. Neurosurgery 2005; 57: 585–593, discussion 585-593.
Jimenez F, Velasco F, Salin-Pascual R, Velasco M, Nicolini H, Velasco AL et al. Neuromodulation of the inferior thalamic peduncle for major depression and obsessive compulsive disorder. Acta Neurochir Suppl 2007; 97 (Pt 2): 393–398.
Jimenez F, Nicolini H, Lozano AM, Piedimonte F, Salin R, Velasco F . Electrical stimulation of the inferior thalamic peduncle in the treatment of major depression and obsessive compulsive disorders. World Neurosurg 2013; 80: S30 e17–25.
Raymaekers S, Luyten L, Bervoets C, Gabriels L, Nuttin B . Deep brain stimulation for treatment-resistant major depressive disorder: a comparison of two targets and long-term follow-up. Transl Psychiatry 2017; 7: e1251.
Faggiani E, Delaville C, Benazzouz A . The combined depletion of monoamines alters the effectiveness of subthalamic deep brain stimulation. Neurobiol Dis 2015; 82: 342–348.
Creed MC, Hamani C, Nobrega JN . Effects of repeated deep brain stimulation on depressive- and anxiety-like behavior in rats: comparing entopeduncular and subthalamic nuclei. Brain Stimul 2013; 6: 506–514.
Schneider F, Habel U, Volkmann J, Regel S, Kornischka J, Sturm V et al. Deep brain stimulation of the subthalamic nucleus enhances emotional processing in Parkinson disease. Arch Gen Psychiatry 2003; 60: 296–302.
Funkiewiez A, Ardouin C, Caputo E, Krack P, Fraix V, Klinger H et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004; 75: 834–839.
Czernecki V, Pillon B, Houeto JL, Welter ML, Mesnage V, Agid Y et al. Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease? J Neurol Neurosurg Psychiatry 2005; 76: 775–779.
Campbell MC, Black KJ, Weaver PM, Lugar HM, Videen TO, Tabbal SD et al. Mood response to deep brain stimulation of the subthalamic nucleus in Parkinson's disease. J Neuropsychiatr Clin Neurosci 2012; 24: 28–36.
Eisenstein SA, Dewispelaere WB, Campbell MC, Lugar HM, Perlmutter JS, Black KJ et al. Acute changes in mood induced by subthalamic deep brain stimulation in Parkinson disease are modulated by psychiatric diagnosis. Brain Stimul 2014; 7: 701–708.
Temel Y, Wilbrink P, Duits A, Boon P, Tromp S, Ackermans L et al. Single electrode and multiple electrode guided electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. Neurosurgery 2007; 61 (5 Suppl 2): 346–355, discussion 355-347.
Aono M, Iga J, Ueno S, Agawa M, Tsuda T, Ohmori T . Neuropsychological and psychiatric assessments following bilateral deep brain stimulation of the subthalamic nucleus in Japanese patients with Parkinson's disease. J Clin Neurosci 2014; 21: 1595–1598.
Bejjani BP, Houeto JL, Hariz M, Yelnik J, Mesnage V, Bonnet AM et al. Aggressive behavior induced by intraoperative stimulation in the triangle of Sano. Neurology 2002; 59: 1425–1427.
Sako W, Miyazaki Y, Izumi Y, Kaji R . Which target is best for patients with Parkinson's disease? A meta-analysis of pallidal and subthalamic stimulation. J Neurol Neurosurg Psychiatry 2014; 85: 982–986.
Mahgoub NA, Kotbi N . Acute depression and suicidal attempt following lowering the frequency of deep brain stimulation. J Neuropsychiatr Clin Neurosci 2009; 21: 468.
Appleby BS, Duggan PS, Regenberg A, Rabins PV . Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: A meta-analysis of ten years' experience. Mov Disord 2007; 22: 1722–1728.
Narang P, Retzlaff A, Brar K, Lippmann S . Deep brain stimulation for treatment-refractory depression. Southern Med J 2016; 109: 700–703.
Zhou C, Zhang H, Qin Y, Tian T, Xu B, Chen J et al. A systematic review and meta-analysis of deep brain stimulation in treatment-resistant depression. Progr Neuropsychopharmacol Biol Psychiatry 2018; 82: 224–232.
Hamani C, Mayberg H, Snyder B, Giacobbe P, Kennedy S, Lozano AM . Deep brain stimulation of the subcallosal cingulate gyrus for depression: anatomical location of active contacts in clinical responders and a suggested guideline for targeting. J Neurosurg 2009; 111: 1209–1215.
Schlaepfer TE . Deep brain stimulation for major depression-steps on a long and winding road. Biol Psychiatry 2015; 78: 218–219.
Schlaepfer TE, Bewernick BH, Kayser S, Hurlemann R, Coenen VA . Deep brain stimulation of the human reward system for major depression—rationale, outcomes and outlook. Neuropsychopharmacology 2014; 39: 1303–1314.
Nestler EJ, Carlezon WA Jr. . The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006; 59: 1151–1159.
Krishnan V, Nestler EJ . Linking molecules to mood: new insight into the biology of depression. Am J Psychiatry 2010; 167: 1305–1320.
Coenen VA, Schlaepfer TE, Allert N, Madler B . Diffusion tensor imaging and neuromodulation: DTI as key technology for deep brain stimulation. Int Rev Neurobiol 2012b; 107: 207–234.
Hoyer C, Sartorius A, Lecourtier L, Kiening KL, Meyer-Lindenberg A, Gass P . One ring to rule them all?—Temporospatial specificity of deep brain stimulation for treatment-resistant depression. Med Hypotheses 2013; 81: 611–618.
Fernandes BS, Williams LM, Steiner J, Leboyer M, Carvalho AF, Berk M . The new field of 'precision psychiatry'. BMC Med 2017; 15: 80.
Guinjoan SM, Mayberg HS, Costanzo EY, Fahrer RD, Tenca E, Antico J et al. Asymmetrical contribution of brain structures to treatment-resistant depression as illustrated by effects of right subgenual cingulum stimulation. J Neuropsychiatr Clin Neurosci 2010; 22: 265–277.
Acknowledgements
The Translational Psychiatry Program (USA) is funded by the Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth). Laboratory of Neurosciences (Brazil) is one of the centers of the National Institute for Molecular Medicine (INCT-MM) and one of the members of the Center of Excellence in Applied Neurosciences of Santa Catarina (NENASC). Its research is supported by grants from CNPq (JQ), FAPESC (JQ); Instituto Cérebro e Mente (JQ) and UNESC (JQ). JQ is a 1A CNPq Research Fellow. Dr Jair C Soares has received grants/research supports from the Pat Rutherford, Jr Endowed Chair in Psychiatry (JCS), John S Dunn Foundation from United States (JCS) and NIMH (R01MH085667-01A1; JCS), Stanley Medical Research Institute, and NIH.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
JCS received research/grant support from Bristol-Meyers Squibb, Forest Laboratories, Merck, Elan Pharmaceuticals, J&J, Stanley Medical Research Institute and has served as a consultant for Pfizer, Abbot and Astellas Pharma. The remaining authors declare no conflict of interest.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Dandekar, M., Fenoy, A., Carvalho, A. et al. Deep brain stimulation for treatment-resistant depression: an integrative review of preclinical and clinical findings and translational implications. Mol Psychiatry 23, 1094–1112 (2018). https://doi.org/10.1038/mp.2018.2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2018.2